News | Vascular Closure Devices | August 17, 2020

Vasorum Partners With Veryan to Commercialize of New Vascular Closure Device in U.S.

Vasorum Partners With Veryan to Commercialize of New Vascular Closure Device in U.S.

August 17, 2020 — Veryan Medical announced it will support Vasorum in the commercialization of the Celt atrial closure device (ACD) in the United States. The Celt ACD is a vascular closure device that has been used in more than 60,000 patients to date with excellent clinical results following percutaneous catheter-based vascular procedures.  

"The Veryan Medical agreement is validation that the Celt ACD has proven itself to be a leading arterial closure device that allows rapid and complete hemostasis independent of vascular anatomy, including calcified arteries. This agreement provides an opportunity to accelerate growth for both companies in the U.S.A.," said James Coleman M.D., Vasorum co-founder and CEO.

“We are pleased to be working with Vasorum and the Celt ACD which has proven to be a game changing closure technology” said Nick Yeo, Veryan Medical’s CEO. “We plan to include the Celt device as an option in our MIMICS-3D USA registry, which will start enrolling later this year."  

MIMICS-3D USA is a prospective, multi-center observational study evaluating the safety, effectiveness and device performance of the BioMimics 3D Vascular Stent System within a real-world clinical population of patients undergoing femoropopliteal intervention. MIMICS-3D-USA will enroll more than 500 patients in 40 clinical sites across the United States and Veryan will conduct a sub-analysis of patients who have had a Celt ACD used in the index procedure.

“I have been using the Celt ACD for several years and have completed over 1,000 implants," said Syed Hussain M.D., chairman of vascular and endovascular surgery at the Christie Clinic in Champaign, Illinois. "The device is extremely easy to use and has unique benefits including rapid haemostasis allowing for safe patient ambulation shortly after the procedure.”

Vasorum has received FDA PMA approval and European CE mark for Celt ACD, which allows rapid closure of an arterial puncture site after percutaneous catheter-based vascular procedures. Celt ACD achieves closure by deploying a biocompatible implant to both the inside and the outside of the puncture site in the arterial wall. Celt ACD is available in three sizes to fit 5, 6 and 7 French sheaths and does not require exchange of the existing procedural sheath before deployment. With more than 60,000 patient implants to date, Celt ACD has proven itself to be a best in class arterial puncture closure device. 

Find other news on vascular closure device technology

For more information: www.vasorum.ie
 


Related Content

News | Vascular Closure Devices

April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home April 16, 2024
Home
News | Vascular Closure Devices

September 16, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced that Dr. Magnus ...

Home September 16, 2022
Home
News | Vascular Closure Devices

November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies ...

Home November 09, 2021
Home
News | Vascular Closure Devices

July 15, 2021 — Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully ...

Home July 15, 2021
Home
Videos | Vascular Closure Devices

Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix, explains the trend ...

Home October 17, 2019
Home
Technology | Vascular Closure Devices

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

Home April 03, 2019
Home
Technology | Vascular Closure Devices

December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food ...

Home December 20, 2018
Home
News | Vascular Closure Devices

November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for ...

Home November 21, 2018
Home
News | Vascular Closure Devices

November 12, 2018 — The Vascade MVP vascular closure system met its endpoints compared to manual compression in a ...

Home November 11, 2018
Home
Technology | Vascular Closure Devices

November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure ...

Home November 05, 2018
Home
Subscribe Now